Tiger Balmproducts are available in more than 80 countries and have been used by overone-third of the

Tiger Balmproducts are available in more than 80 countries, and have been used by overone-third of the world's population for nearly 100 years.Tiger Balm made itsway onto health food store shelves during the 1970's and, in the 1980's, thebrand entered the mainstream spotlight when San Francisco 49ers quarterbackJoe Montana had a back injury and was sent a jar of Tiger Balm to help himrecover He later became Tiger Balm's first prominent U.S spokesperson. Itis trusted and used by people looking for a unique and proven Asian herbalformulation to relieve an array of muscular aches and pains. Its soothing, pleasant scent and the gentle rubbingof the product around the neck and shoulder areas provide a rejuvenating,de-stressing effect for today's stressed office workers.The product ispacked in a handy, compact tube to make it convenient for consumers to carrywith them for an on-the-go massage whenever they need one.Visit for more details.About Tiger BalmTiger Balm has grown to become one of the world's leading pain relievers. The award-winningpackaging design gives the product a trendy and modern look, which projects apremium higher-end feel. People sufferingfrom neck and shoulder pains may think that there is nothing they can do aboutit.

"We'repleased to help New Yorkers manage their stress and relieve their pain bylaunching a new neck and shoulder pain version of Tiger Balm. TORONTO, ONTARIO, Apr 28 (MARKET WIRE) -- Bio-Extraction Inc. (TSX VENTURE: BXI) ("BioExx") is pleased to announceit has priced a private placement of 5,800,000 Common Shares at $0.52 pershare for gross proceeds of $3,016,000 (the "Private Placement"). Closingof the Private Placement is scheduled for May 12, 2008, subject to theapproval of the TSX Venture Exchange and other customary conditions. TheCommon Shares will be subject to a four month statutory hold period.Canaccord Capital Corporation acted as lead agent on the PrivatePlacement, and Fraser Mackenzie Limited, Loewen Ondaatje McCutcheonLimited, and Wellington West Capital Markets Inc (collectively, the"Agents") also participated. The Agents have the option to increase thenumber of Common Shares sold on the Private Placement up to 9,800,000.

This capital represents a prudent strengthening of ourbalance sheet for our shareholders, and it does so at a time of difficultand highly uncertain capital market conditions. It also augments ourability to continue on our path of consistent and successful businessplan execution, and further drives our tireless efforts towardsexploitation of high-end protein markets", said Chris Schnarr, ChiefFinancial Officer of BioExx.About Bio-Extraction Inc.Headquartered in Toronto, Canada, BioExx is a leading technology companyfocused on the extraction of oil and high-value proteins from oilseedsfor the global food market. BioExx' patented technology allows for theuse of significantly lower temperatures than conventional methods inextracting the active ingredients and oils from oilseeds, resulting inhigher yields and higher-quality meal, oils and proteins. BioExx' lowenergy requirements, environmentally sound process, and high-yieldproduction have the potential to make a valuable contribution inalleviating food scarcity.

BioExx operates a commercial scale extractionfacility in Saskatoon, Saskatchewan, and has a mission to constructadditional and larger processing facilities on a global basis To findout more about Bio-Extraction Inc. (TSX VENTURE: BXI), please visit statements made in this press release include forward-lookingstatements that involve a number of risks and uncertainties. Thesestatements relate to future events or future performance and reflectmanagement's current expectations and assumptions. A number of factorscould cause actual events, performance or results to differ materiallyfrom the events, performance and results discussed in the forward-lookingstatements, such as the economy, generally, the demand for BioExx'products, the availability of funding, and the anticipated costs ofBioExx' plant construction and operation. These forward-lookingstatements are made as of the date hereof and BioExx does not assume anyobligation to update or revise them to reflect new events orcircumstances.